SCHEMBL19652009

SCHEMBL19652009

Cc1ccc(N(c2ccc(C)cc2)c2ccc(C=C3C(=O)N(C)C(=O)N(C)C3=O)o2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.58
ALDH1A1 P00352 10/20 0.58
NPSR1 Q6W5P4 2/20 0.58
GFER P55789 1/20 0.58
KMT2A Q03164 15/20 0.57
MEN1 O00255 14/20 0.57
RAB9A P51151 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPC1 O15118 2/20 0.51
IDE P14735 1/20 0.51
POLB P06746 6/20 0.47
HPGD P15428 3/20 0.47
PKM P14618 4/20 0.44
TDP1 Q9NUW8 4/20 0.44
MYC P01106 1/20 0.40
KDM4E B2RXH2 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19652025 0.91 MAPT (0.70) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL19652004 0.86 MAPT (0.63) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL19652003 0.85 MAPT (0.47) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL19652021 0.79 MAPT (0.72) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL19652005 0.76 KMT2A (0.48) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL4603774 0.75 MAPT (0.59) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL19652020 0.74 ESR2 (0.49) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL15044605 0.70 MAPT (0.65) MAPTALDH1A1NPSR1GFERKMT2A
SCHEMBL22108463 0.69 MAPT (0.42) MAPTALDH1A1NPSR1KMT2AMEN1
SCHEMBL19652016 0.67 MAPT (0.51) MAPTALDH1A1NPSR1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960362-B2 Compound and organic photoelectric device, image sensor and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-9960362-B2 Compound and organic photoelectric device, image sensor and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co .. Ltd. (KR) 2017-11-30 US disclosed
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co .. Ltd. (KR) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME PPOX, PIEZO1, CYP1A1 MAPT 2370/4885ALDH1A1 42/4885NPSR1 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.